Elon Musk's brain chip firm Neuralink has said it has been given the go-ahead to start carrying out studies on humans. Neuralink said in a tweet on Thursday it had won the approval of the US Food and Drug Administration (FDA) "to launch our first-in-human clinical study!" It represents "an important first step that will…